Compare COGT & POOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COGT | POOL |
|---|---|---|
| Founded | 2014 | 1993 |
| Country | United States | United States |
| Employees | N/A | 6000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.7B |
| IPO Year | 2018 | 1997 |
| Metric | COGT | POOL |
|---|---|---|
| Price | $34.73 | $181.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 10 |
| Target Price | $36.21 | ★ $274.43 |
| AVG Volume (30 Days) | ★ 1.6M | 848.2K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.45 |
| Revenue | $7,871,000.00 | ★ $5,289,396,000.00 |
| Revenue This Year | N/A | $4.30 |
| Revenue Next Year | $1,733.58 | $3.84 |
| P/E Ratio | ★ N/A | $127.52 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.10 | $172.68 |
| 52 Week High | $43.73 | $345.00 |
| Indicator | COGT | POOL |
|---|---|---|
| Relative Strength Index (RSI) | 50.38 | 38.39 |
| Support Level | $33.26 | $172.68 |
| Resistance Level | $37.69 | $250.38 |
| Average True Range (ATR) | 1.34 | 5.56 |
| MACD | 0.24 | 1.20 |
| Stochastic Oscillator | 72.74 | 53.49 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Pool Corp is a wholesale distributor of swimming pool supplies, equipment, and related leisure products. The company's products include pool pumps, filters, heaters, and cleaners; pool maintenance products like chemicals, supplies, and repair parts; irrigation and landscape maintenance products; and outdoor lighting, grills, outdoor kitchen components, etc. These products are offered through branded distribution networks such as Horizon, SCP, Poolcorp Commercial Aquatics, Sun Wholesale Supply, Superior Pool Products, and NPT. The company's customers include pool builders, pool service companies, retail stores, commercial pool operators, and landscape contractors. Geographically, it generates maximum revenue from the United States, followed by other markets like Europe and Australia.